Health
FDA schedules meeting to discuss emergency use authorization of COVID-19 vaccine from Pfizer – News-Medical.Net
The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10 to discuss…
Reviewed by Emily Henderson, B.Sc.Nov 23 2020
The U.S. Food and Drug Administration has request for emergency use authorization a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10 to discuss the request for emergency use authorization (EUA) of a COVID-19 vaccine from Pfizer, Inc. in partnership with BioNTech Manufacturing GmbH.
The FDA recognizes that transparency and dialogue are critical for the public to have confidence in COVID-19 vaccines. I want…
-
Business21 hours agoForget CBA and buy these high-yield ASX dividend shares
-
Business24 hours ago5 easy steps to build a $100,000 ASX share portfolio
-
Noosa News24 hours agoThe rent crisis behind Australia’s two-faced cities
-
Noosa News21 hours agoThe Almond Ashes sees Australia and India mix business and cricket